Relapsing Thrombotic Thrombocytopenic Purpura (TTP) in a Patient Treated with Infliximab for Chronic Uveitis

被引:3
作者
Mopuru, Renuka [1 ]
Chaturvedi, Shruti [2 ]
Burkholder, Bryn M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA
关键词
Thrombotic thrombocytopenic purpura; infliximab; uveitis; ADAMTS13; drug-induced thrombotic microangiopathy; FACTOR-CLEAVING PROTEASE; MICROANGIOPATHY;
D O I
10.1080/09273948.2020.1797117
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To report a case of relapsing thrombotic thrombocytopenic purpura (TTP) in a patient treated with infliximab for chronic uveitis. Case report A 57-year-old African American woman with chronic anterior and intermediate uveitis, treated with infliximab for more than 1 year, presented with fatigue, dark colored urine, and ecchymosis on her extremities. She was diagnosed with thrombotic thrombocytopenic purpura (TTP) and recovered after treatment. After a remission period of 8 months, she was treated again with infliximab for recurrent intraocular inflammation. She developed a relapse of TTP 4 weeks after reintroducing infliximab. Conclusion Relapsing thrombotic thrombocytopenic purpura can be a rare complication associated with infliximab. To our knowledge, it has not been reported in the literature to date.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 18 条
[1]   Drug-induced thrombotic microangiopathy: a systematic review of published reports [J].
Al-Nouri, Zayd L. ;
Reese, Jessica A. ;
Terrell, Deirdra R. ;
Vesely, Sara K. ;
George, James N. .
BLOOD, 2015, 125 (04) :616-618
[2]   Immunogenicity and autoimmunity during anti-TNF therapy [J].
Atzeni, F. ;
Talotta, R. ;
Salaffi, F. ;
Cassinotti, A. ;
Varisco, V. ;
Battellino, M. ;
Ardizzone, S. ;
Pace, F. ;
Sarzi-Puttini, P. .
AUTOIMMUNITY REVIEWS, 2013, 12 (07) :703-708
[3]   The role of TNF superfamily members in T-cell function and diseases [J].
Croft, Michael .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (04) :271-285
[4]   Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy:: a French national survey [J].
De Bandt, M ;
Sibilia, J ;
Le Loët, X ;
Prouzeau, S ;
Fautrel, B ;
Marcelli, C ;
Boucquillard, E ;
Siame, JL ;
Mariette, X .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) :R545-R551
[5]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[6]   Survival and relapse in patients with thrombotic thrombocytopenic purpura [J].
Hovinga, Johanna A. Kremer ;
Vesely, Sara K. ;
Terrell, Deirdra R. ;
Laemmle, Bernhard ;
George, James N. .
BLOOD, 2010, 115 (08) :1500-1511
[7]   Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers [J].
Hrdinova, Johana ;
D'Angelo, Silvia ;
Graca, Nuno A. G. ;
Ercig, Bogac ;
Vanhoorelbeke, Karen ;
Veyradier, Agnes ;
And, Jan Voorberg ;
Coppo, Paul .
HAEMATOLOGICA, 2018, 103 (07) :1099-1109
[8]  
Mariotte E, 2016, LANCET HAEMATOL, V3, pE237, DOI [10.1016/S2352-3026(16)30018-7, 10.1016/s2352-3026(16)30018-7]
[9]   UNUSUALLY LARGE PLASMA FACTOR-VIII - VONWILLEBRAND-FACTOR MULTIMERS IN CHRONIC RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA [J].
MOAKE, JL ;
RUDY, CK ;
TROLL, JH ;
WEINSTEIN, MJ ;
COLANNINO, NM ;
AZOCAR, J ;
SEDER, RH ;
HONG, SL ;
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (23) :1432-1435
[10]  
Moschcowitz E., 1924, PROC N PATHOL SOC, V24, P21